United BioSource, LLC

United BioSource, LLC (UBC) is a healthcare consulting organization focusing on safety and compliance in pharmaceuticals. The firm specializes in providing consulting services to help pharmaceutical companies navigate regulatory requirements, ensure patient safety, and optimize clinical research operations.

CCI Score

-4.30

0.01% April 18

Latest Event

Modest Political Finance Activity in 2024 Cycle

United BioSource, LLC reported modest campaign contributions of $4,750 in the 2024 cycle and no lobbying expenses, indicating minimal political involvement. This limited financial engagement suggests a restrained approach to political influence, which aligns with anti-authoritarian practices.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: Ibex

Deloitte Consulting

MRFF
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

BYSTANDER

United BioSource, LLC is currently rated as a Bystander.

-1 to -4 CCI Score

Companies scoring here do little to oppose authoritarianism. Their inaction results in a passive endorsement of the status quo, as they neither actively resist oppression nor contribute to overt support for it.

Latest Events

FEB

06

2025

Modest Political Finance Activity in 2024 Cycle
9.81

United BioSource, LLC reported modest campaign contributions of $4,750 in the 2024 cycle and no lobbying expenses, indicating minimal political involvement. This limited financial engagement suggests a restrained approach to political influence, which aligns with anti-authoritarian practices.
+10

Political Contributions and Lobbying Efforts

March 28

The company's small contribution amount and absence of lobbying activities in the 2024 cycle indicate a minimal role in political financing. Such limited engagement reduces the risk of supporting authoritarian agendas, representing a mildly positive stance from an anti-fascist perspective.
FEB

06

2025

United BioSource Corp Political Contributions Overview (2024 Cycle)
4.90

The OpenSecrets profile for United BioSource Corp shows a modest political contribution of $4,750 in the 2024 cycle, with no reported lobbying or outside spending. This limited political involvement suggests minimal influence on political processes and indicates no apparent support for authoritarian practices.
+5

Political Contributions and Lobbying Efforts

March 28

The reported political contribution is modest, and the absence of lobbying or outside spending indicates a low risk of exerting undue influence on politics. This limited engagement minimizes the risk of enabling authoritarian tendencies, reflecting a slightly positive stance from an anti-fascist perspective.

United BioSource Corp Profile: Summary • OpenSecrets
MAR

08

2023

UBC Launches Inclusive Decentralized Research Offering with THREAD
52.60

On March 8, 2023, United BioSource, LLC partnered with THREAD to launch SitePlus, a new, decentralized research model that expands patient recruitment and enhances inclusivity in post-approval clinical studies. The initiative leverages innovative technology to optimize evidence generation while improving patient experience.
+60

Business Practices and Ethical Responsibility

March 28

The launch of SitePlus represents a progressive business practice by enhancing patient engagement and promoting inclusivity in clinical research. By addressing patient recruitment challenges and optimizing evidence generation in post-approval studies, UBC demonstrates a commitment to ethical responsibility within the healthcare sector.

UBC Selects THREAD to Launch New SitePlus Offering and Optimize Evidence Generation
+70

Technology and Services Impact

March 28

The partnership leverages THREAD's innovative technology platform to support UBC’s new SitePlus offering. This technological integration is aimed at streamlining clinical research processes and expanding access to diverse patient populations, thus delivering a positive impact on healthcare services.

UBC Selects THREAD to Launch New SitePlus Offering and Optimize Evidence Generation
DEC

20

2019

Racketeering Lawsuit Over Acthar Price Inflation
-46.93

United BioSource LLC is named in a racketeering suit alleging that it participated in a scheme to overcharge for the multiple sclerosis drug Acthar, inflating its price from $40 in 2001 to $39,000 by 2018. The lawsuit, advanced by a steamfitters union, accuses the company of fraud, unfair competition, and consumer exploitation.
-80

Business Practices and Ethical Responsibility

March 28

The lawsuit against United BioSource LLC alleges that the company engaged in a scheme to drastically inflate the price of Acthar, reflecting unethical business practices and exploitation of consumers. Such behavior disproportionately affects vulnerable patients and contributes to broader systemic inequities in healthcare, marking a clear negative impact from an ethical and social responsibility perspective.

Union's Acthar Racketeering Suit Advances Against Mallinckrodt
JUN

24

2019

Fraudulent Business Sale Leads to $82M Judgment
-41.89

United BioSource, LLC was found by a Delaware jury on June 24, 2019 to have engaged in fraudulent behavior by manipulating revenue and earnings in a 2013 clinical software business sale, resulting in an $82.1 million liability as detailed in the lawsuit against Express Scripts and UBC.
-75

Business Practices and Ethical Responsibility

March 28

The fraudulent overstatement of revenue and earnings represents a severe breach of ethical business practices. UBC’s manipulations not only deceived business partners but also resulted in a hefty legal penalty, thereby undermining corporate accountability and ethical standards.

Express Scripts, UBC Must Pay $82 Million in Delaware Fraud Suit